Showing results (41-50 of 290) with videos related to
Sort By:
Pageof 29
Oncotarget|December 12, 2018
Comprehensive genomic profiling identifies novel NTRK fusions in neuroendocrine tumorsDarren S Sigal, Munveer S Bhangoo, Jonathan A Hermel, et al.Archives of Pathology & Laboratory Medicine|March 6, 2009
Morphologic features of adenocarcinoma of the lung predictive of response to the epidermal growth factor receptor kinase inhibitors erlotinib and gefitinibMaureen F Zakowski, Sanaa Hussain, William Pao, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 27, 2016
Emergence of Preexisting MET Y1230C Mutation as a Resistance Mechanism to Crizotinib in NSCLC with MET Exon 14 SkippingSai-Hong Ignatius Ou, Lauren Young, Alexa B Schrock, et al.The Journal of Molecular Diagnostics : JMD|April 12, 2008
EGFR mutations in lung adenocarcinomas: clinical testing experience and relationship to EGFR gene copy number and immunohistochemical expressionAllan R Li, Dhananjay Chitale, Gregory J Riely, et al.Case Reports in Oncology|May 14, 2020
Exceptional Response to Everolimus in a Patient with Metastatic Castrate-Resistant Prostate Cancer Harboring a PTEN Inactivating MutationJamie A Kmak, Nikita Agarwal, Yuting He, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 8, 2010
Acquired resistance to EGFR tyrosine kinase inhibitors in EGFR-mutant lung cancer: distinct natural history of patients with tumors harboring the T790M mutationGeoffrey R Oxnard, Maria E Arcila, Camelia S Sima, et al.Cancer Chemotherapy and Pharmacology|April 16, 2003
A phase I trial of perillyl alcohol in patients with advanced solid tumorsChristopher G Azzoli, Vincent A Miller, Kenneth K Ng, et al.American Journal of Clinical Oncology|June 11, 2003
Gemcitabine-induced peripheral edema: report on 15 cases and review of the literatureChristopher G Azzoli, Vincent A Miller, Kenneth K Ng, et al.Head & Neck|September 23, 2016
Genomic alterations in human epidermal growth factor receptor 2 (HER2/ERBB2) in head and neck squamous cell carcinomaChristine H Chung, Alexis Germain, Rathan M Subramaniam, et al.Journal of Neuro-Oncology|December 12, 2018
Comprehensive genetic alteration profiling in primary and recurrent glioblastomaBeth K Neilsen, Richard Sleightholm, Rodney McComb, et al.Pageof 29